Skip to main content

Advertisement

Figure 3 | Clinical and Translational Allergy

Figure 3

From: Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial

Figure 3

Summary of the time course of maximum percentage change in post-saline baseline FEV 1 . Therapy was dosed between 6 pm and 8 pm on Days 1–28 and the allergen challenge initiated on Day 29 (between 4 pm and 7 pm). FEV1 = forced expiratory volume in 1 s; FF = fluticasone furoate; SE = standard error; VI = vilanterol. Not all subjects contributed data to all time points

Back to article page